Jasper Mullenders

Jasper Mullenders has a diverse and extensive work experience in various scientific and research roles. Jasper is currently serving as the Director of Translational Biology at Scenic Biotech since August 2021. Prior to this, they held several positions at Hubrecht Organoid Technology, including Head of Department - Oncology from October 2020 to August 2021, Group Leader Oncology Program from August 2019 to October 2020, and Group Leader Cystic Fibrosis from May 2018 to August 2019.

Before joining Hubrecht Organoid Technology, Jasper Mullenders worked at the Hubrecht Institute, Developmental Biology and Stem Cell Research. Jasper served as a Senior Scientist from May 2017 to May 2018 and as a Postdoctoral Fellow from December 2015 to May 2017.

Prior to their time at the Hubrecht Institute, Jasper Mullenders was a Postdoctoral Fellow at NYU Langone Medical Center, where they worked from September 2010 to October 2015.

Jasper Mullenders started their career as a PhD student at NKI from January 2003 to December 2009, focusing on their research in the field. Jasper also had a brief role as a Student at Unilever Research in 1999.

Overall, Jasper Mullenders has gained valuable expertise and knowledge through their progressive roles in various scientific and research institutions.

Jasper Mullenders completed their education chronologically as follows:

From 1990 to 1996, Jasper attended College Leeuwenhorst for their secondary education. It is not specified whether they obtained a degree or pursued a specific field of study during this time.

Jasper then enrolled at Leiden University from 1996 to 2002. Jasper earned a Master of Science (MSc) degree in Chemistry during their time at the university.

Following their studies at Leiden University, Jasper pursued further education at the University of Southern California from 2001 to 2002. Jasper obtained a Master of Science (MSc) degree in Biochemistry and Molecular Biology during their time at USC.

Finally, Jasper completed their Ph.D. at Utrecht University between 2003 and 2009. Jasper specialized in the field of Molecular Carcinogenesis and was awarded a Ph.D. degree.